Logo image of OBCI

OCEAN BIO-CHEM INC (OBCI) Stock Fundamental Analysis

USA - NASDAQ:OBCI - US6746311066 - Common Stock

13.03 USD
-0.01 (-0.08%)
Last: 8/8/2022, 8:00:02 PM
13.07 USD
+0.04 (+0.31%)
After Hours: 8/8/2022, 8:00:02 PM
Fundamental Rating

2

Overall OBCI gets a fundamental rating of 2 out of 10. We evaluated OBCI against 12 industry peers in the Household Products industry. While OBCI seems to be doing ok healthwise, there are quite some concerns on its profitability. OBCI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OBCI had positive earnings in the past year.
OBCI Yearly Net Income VS EBIT VS OCF VS FCFOBCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 12.58%
ROE 16.11%
ROIC 13.99%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OBCI Yearly ROA, ROE, ROICOBCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 5 10 15 20

1.3 Margins

Industry RankSector Rank
OM 15.74%
PM (TTM) 12.2%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OBCI Yearly Profit, Operating, Gross MarginsOBCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

OBCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
OBCI has more shares outstanding than it did 1 year ago.
OBCI has a worse debt/assets ratio than last year.
OBCI Yearly Shares OutstandingOBCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M
OBCI Yearly Total Debt VS Total AssetsOBCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

OBCI has an Altman-Z score of 8.61. This indicates that OBCI is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.16 indicates that OBCI is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 8.61
ROIC/WACC1.92
WACC7.29%
OBCI Yearly LT Debt VS Equity VS FCFOBCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 7.74 indicates that OBCI has no problem at all paying its short term obligations.
A Quick Ratio of 4.14 indicates that OBCI has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 7.74
Quick Ratio 4.14
OBCI Yearly Current Assets VS Current LiabilitesOBCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for OBCI have decreased strongly by -28.57% in the last year.
Measured over the past years, OBCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.75% on average per year.
The Revenue has been growing slightly by 4.99% in the past year.
Measured over the past years, OBCI shows a quite strong growth in Revenue. The Revenue has been growing by 12.17% on average per year.
EPS 1Y (TTM)-28.57%
EPS 3Y43.4%
EPS 5Y30.75%
EPS Q2Q%-31.83%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y15.44%
Revenue growth 5Y12.17%
Sales Q2Q%-2.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OBCI Yearly Revenue VS EstimatesOBCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OBCI is valuated correctly with a Price/Earnings ratio of 15.89.
When comparing the Price/Earnings ratio of OBCI to the average of the S&P500 Index (26.35), we can say OBCI is valued slightly cheaper.
Industry RankSector Rank
PE 15.89
Fwd PE N/A
OBCI Price Earnings VS Forward Price EarningsOBCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.52
OBCI Per share dataOBCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.52
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.23%, OBCI has a reasonable but not impressive dividend return.
Compared to an average S&P500 Dividend Yield of 2.36, OBCI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.23%

5.2 History

OBCI has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
OBCI Yearly Dividends per shareOBCI Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

15.89% of the earnings are spent on dividend by OBCI. This is a low number and sustainable payout ratio.
DP15.89%
EPS Next 2YN/A
EPS Next 3YN/A
OBCI Yearly Income VS Free CF VS DividendOBCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 2M -2M 4M 6M 8M
OBCI Dividend Payout.OBCI Dividend Payout, showing the Payout Ratio.OBCI Dividend Payout.PayoutRetained Earnings

More info and screens

OCEAN BIO-CHEM INC

NASDAQ:OBCI (8/8/2022, 8:00:02 PM)

After market: 13.07 +0.04 (+0.31%)

13.03

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)05-27 2022-05-27/bmo
Earnings (Next)08-30 2022-08-30/bmo
Inst Owners0.9%
Inst Owner Change-89.22%
Ins Owners61.67%
Ins Owner Change0%
Market Cap123.91M
Revenue(TTM)63.90M
Net Income(TTM)7.80M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.23%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP15.89%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.89
Fwd PE N/A
P/S 1.94
P/FCF N/A
P/OCF N/A
P/B 2.56
P/tB N/A
EV/EBITDA 10.52
EPS(TTM)0.82
EY6.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.72
BVpS5.09
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.52
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 12.58%
ROE 16.11%
ROCE N/A
ROIC 13.99%
ROICexc N/A
ROICexgc 14.32%
OM 15.74%
PM (TTM) 12.2%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.74
Quick Ratio 4.14
Altman-Z 8.61
F-Score3
WACC7.29%
ROIC/WACC1.92
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3Y43.4%
EPS 5Y30.75%
EPS Q2Q%-31.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y15.44%
Revenue growth 5Y12.17%
Sales Q2Q%-2.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

OCEAN BIO-CHEM INC / OBCI FAQ

What is the ChartMill fundamental rating of OCEAN BIO-CHEM INC (OBCI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to OBCI.


What is the valuation status of OCEAN BIO-CHEM INC (OBCI) stock?

ChartMill assigns a valuation rating of 6 / 10 to OCEAN BIO-CHEM INC (OBCI). This can be considered as Fairly Valued.


Can you provide the profitability details for OCEAN BIO-CHEM INC?

OCEAN BIO-CHEM INC (OBCI) has a profitability rating of 5 / 10.


Can you provide the dividend sustainability for OBCI stock?

The dividend rating of OCEAN BIO-CHEM INC (OBCI) is 3 / 10 and the dividend payout ratio is 15.89%.